BioNTech CEO Ugur Sahin said Friday that while there were concerns the Pfizer-BioNTech vaccine may not be as effective against the new Omicron COVID-19 variant, it was possible to quickly adapt the current shot to combat the variant.
COVID-19
COVID-19: BioNTech CEO says it’s possible to quickly adapt Pfizer vaccine for Omicron
More Videos
-
Health Matters: China froze COVID-19 origin tracing, AP investigation finds
-
Scottish researchers ‘chewing’ their way toward solution in global plastics pollution issue
-
Canadian businesses worried as CEBA repayment deadline looms
-
Health Matters: Yale Public Health researchers recommend annual COVID-19 vaccination
-
Health Matters: Life expectancy has dropped 1.6 years, analysis finds
-
Canadian Covid Society formed
You are viewing an Accelerated Mobile Webpage.
View Original Article